Christopher Pease (C Pease)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Mycobacterium Tuberculosis

Advanced Cancer

Top Venues

International journal of circumpolar health

BMC infectious diseases

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

G G Alvarez, D Van Dyk, R Mallick, S Lesperance, P Demaio, S Finn, S Edmunds Potvin, M Patterson, Christopher Pease, K Amaratunga, C Hui, Donald William Cameron, S Mulpuru, Shawn D Aaron, F Momoli, Alice Anne Zwerling
The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study. International journal of circumpolar health 79 (1) (2021)
Christopher Pease, Gonzalo Alvarez, Ranjeeta Mallick, Mike Patterson, Sandy Finn, Yahya Habis, Kevin Schwartzman, Elaine Kilabuk, Sunita Mulpuru, Alice Zwerling
Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting. BMJ open 11 (5) (2021)
Christopher Pease, Alice Zwerling, Ranjeeta Mallick, Mike Patterson, Patricia Demaio, Sandy Finn, Jean Allen, Deborah Van Dyk, Gonzalo G Alvarez
The latent tuberculosis infection cascade of care in Iqaluit, Nunavut, 2012-2016. BMC infectious diseases 19 (1) (2019)
Christopher Pease, Brian Hutton, Fatemeh Yazdi, Dianna Wolfe, Candyce Hamel, Pauline Barbeau, Becky Skidmore, Gonzalo G Alvarez
A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection. Pharmacoepidemiology and drug safety 27 (6) (2018)